High-sensitivity cardiac troponin T levels in newly diagnosed hypertensive patients with different left ventricle geometry

Blood Pressure

Volumn 23, Issue 4, 2014, Pages 240-247

  Uçar, Hakan ^a   Gür, Mustafa ^a   Kivrak, Ali ^a   Koyunsever, Nermin Yildiz ^a   Şeker, Taner ^a   Akilli, Rabia Eker ^a   Türkoǧlu, Caner ^a   Kaypakli, Onur ^a   Şahin, Durmuş Yildiray ^a   Elbasan, Zafer ^a   Tanboǧa, Halil Ibrahim ^b   Çayli, Murat ^a  

^a Numune Training and Research Hospital   (Turkey)

^b ATATURK UNIVERSITY   (Turkey)

Author keywords

Geometry; High sensitivity troponin; Hypertension; Hypertrophy

Indexed keywords

C REACTIVE PROTEIN; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH SENSITIVITY CARDIAC TROPONIN T; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TROPONIN T; UNCLASSIFIED DRUG; URIC ACID;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPH; FEMALE; GEOMETRY; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ECHOCARDIOGRAPHY; ECHOGRAPHY; METABOLISM; PATHOLOGY; PROCEDURES; PROGNOSIS;

ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PROGNOSIS; TROPONIN T;

EID: 84904699608     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2013.840429     Document Type: Article

References (33)

1. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009; 361: 858-867.
2. Lowbeer C, Gustafsson SA, Seeberger A, Bouvier F, Hulting J. Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction. Scand J Clin Lab Invest. 2004; 64: 667-676.
3. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. J Am Med Assoc. 2010; 304: 2503-2512.
4. Saunders JT, Nambi V, de Lemos JA, Chambless LE, Virani SS, Boerwinkle E, et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation. 2011; 123: 1367-76.
5. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am Coll Cardiol. 2007; 50: 2173-95.
6. Koren M J, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991; 114: 345-352.
7. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992; 19: 1550-1558.
8. Hoshide S, Fukutomi M, Eguchi K, Watanabe T, Kabutoya T, Kario K. Clinical and Change in high-sensitive cardiac troponin T on hypertensive treatment. Exp Hypertens. 2013; 35: 40-44.
9. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al.; Chamber Quantification Writing Group. Recommendations for Chamber Quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18: 1440-1463.
10. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989; 2: 358-367.
11. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977; 55: 613-618.
12. Friehs I, del Nido PJ. Increased susceptibility of hypertro-phied hearts to ischemic injury. Ann Thorac Surg. 2003; 75: S678-684.
13. Negri F, Sala C, Re A, Mancia G, Cuspidi C. Left ventricular geometry and diastolic function in the hypertensive heart: Impact of age. Blood Press. 2013; 22: 1-8.
14. Appleton CP, Hatle LK, Popp RL. Relation of transmitral flow velocity patterns to left ventricular diastolic function: New insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol. 1988; 12: 426-440.
15. Chenevier-Gobeaux C, Meune C, Freund Y, Wahbi K, Claessens YE, Doumenc B, et al. Influence of age and renal function on high-sensitivity cardiac troponin T diagnostic accuracy for the diagnosis of acute myocardial infarction. Am J Cardiol. 2013 doi:pii: S0002-9149(13)00627-9. 10.1016/j. amjcard.2013.02.024.
16. Sato Y, Yamamoto E, Sawa T, Toda K, Hara T, Iwasaki T, et al. High-sensitivity cardiac troponin T in essential Hypertension. J Cardiol. 2011; 58: 226-231.
17. Høiseth AD, Omland T, Hagve T, Brekke PH, Søyseth V. Determinants of high-sensitivity cardiac troponin T during acute exacerbation of chronic obstructive pulmonary disease: A prospective cohort study. BMC Pulmonary Med. 2012; 12: 22.
18. Setsuta K, Kitahara Y, Arae M, Ohbayashi T, Seino Y, Mizuno K. Elevated cardiac troponin T predicts adverse outcomes in hypertensive patients. Int Heart J. 2011; 52: 164-169.
19. Krumolz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol. 1995; 25: 879-84.
20. Dahlöf B, Devereux R, de Faire U, Fyhrquist F, Hedner T, Ibsen H, et al. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: Rationale, design, and methods. The LIFE Study Group. Am J Hypertens. 1997; 10: 705-13.
21. Mishra RK, Li Y, DeFilippi C, Fischer MJ, Yang W, Keane M, et al. Association of cardiac troponin T with left ventricular structure and function in CKD. Am J Kidney Dis. 2013; 61: 701-709.
22. Krauser DG, Devereux RB. Ventricular hypertrophy and hypertension: Prognostic elements and implications for management. Herz. 2006; 31: 305-316.
23. Díez J, Querejeta R, López B, González A, Larman M, Martínez Ubago JL. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation. 2002; 105: 2512-2517.
24. González A, Fortuño MA, Querejeta R, Ravassa S, López B, López N, et al. Cardiomyocyte apoptosis in hypertensive cardiomyopathy. Cardiovasc Res. 2003; 59: 549-562.
25. Weber KT. Fibrosis and hypertensive heart disease. Curr Opin Cardiol. 2000; 15: 264-272
26. Tei C, Nishimura RA, Seward JB, Tajik AJ. Noninvasive Doppler-derived myocardial performance index: Correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr. 1997; 10: 169-178.
27. Hickman PE, Potter JM, Aroney C, Koerbin G, Southcott E, Wu AH, et al. Cardiac troponin may be released by ischemia alone, without necrosis. Clin Chim Acta. 2010; 411: 318-323.
28. Bakal RB, Hatipoglu S, Kahveci G, Omaygenc MO, Unkun T, Akgun T, et al. Determinants of high sensitivity troponin T concentration in chronic stable patients with heart failure: Ischemic heart failure versus non-ischemic dilated cardiomyo-pathy. Cardiol J. 2013 Jun 25. doi: 10.5603/CJ.a2013. 0061.
29. Kitagawa M, Sugiyama H, Morinaga H, Inoue T, Takiue K, Kikumoto Y, et al. Serum high-sensitivity cardiac troponin T is a significant biomarker of left-ventricular diastolic dysfunction in subjects with non-diabetic chronic kidney disease. Nephron Extra. 2011; 1: 166-77. doi: 10.1159/000333801. Epub 2011 Oct 25.
30. Drazner MH. The progression of hypertensive heart disease. Circulation. 2011; 123: 327-34. doi: 10.1161/CIRCULATIONAHA.108.845792. Review.
31. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: A meta-analysis. Circulation. 2005; 112: 3088-3096.
32. Diris JH, Hackeng CM, Kooman JP, Pinto YM, Hermens WT, van Dieijen-Visser MP. Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation. 2004; 109: 23-5.
33. Solaro RJ. Troponin I, stunning, hypertrophy, and failure of the heart. Circ Res. 1999; 84: 122-124.